Prix Blueberries Medical Corp. (BBRRF)

Blueberries Medical Corp. is engaged in the production and distribution of psychoactive and non-psychoactive cannabis by-products. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-04-09. The firm is fully licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis in Colombia. The firm is focusing on cultivating, processing, and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. Additionally, the Company distributes functional supplements, wellness products, and natural ingredients. The Company’s subsidiaries include Blueberries Research Corporation (BRC) and Blueberries SAS (BBSAS). BBSAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.